Gene Therapies Market: A Diverse Range Of Technologies with A Promising Long-Term Outlook Forecast to 2021Medgadget (blog)Gene Therapies Market: A Diverse Range of Technologies with a Promising Long-Term Outlook discusses all gene therapies under the b… Continue reading
MIT Technology Review |
Startup Aims to Treat Muscular Dystrophy with CRISPR
MIT Technology Review A foundation representing boys dying from muscular dystrophy says it will try to cure the disease using CRISPR, a breakthrough method of correcting DNA. CureDuchenne, a patient charity based in Newport Beach, California, says it will spend $5 million … Exonics to use CRISPR in an effort to treat majority of DMD boysFierceBiotech CureDuchenne Ventures Commits $5M to Startup with CRISPR-Based DMD TherapyGenetic Engineering & Biotechnology News Nonprofit Seeds Exonics to Fund Push For CRISPR Duchenne TreatmentXconomy Endpoints News –GlobeNewswire (press release) –Business Wire (press release) all 11 news articles » |
OncLive |
Combos Mark Next Step in Melanoma Immunotherapy
OncLive Evidence continues to build for the long-term efficacy of PD-1–targeting immunotherapies in melanoma, including fresh data indicating when patients can stop taking the drugs and still maintain a response, according to Tara C. Gangadhar, MD. The future … |
Yahoo Finance |
Blood-Based Diagnostic Assay from Biodesix Measures Immunotherapy Biomarker PD-L1
Yahoo Finance Dr. Michael Pritchett: “Understanding PD-L1 status is a central question in immuno-oncology.” (Photo: Business Wire) Multimedia Gallery URL. More. BOULDER, Colo.–(BUSINESS WIRE)–. New data from Biodesix® evaluating an assay in development … |
Rare Disease Report |
CureDuchenne Ventures Invests $5 Million in Duchenne Gene Therapy
Rare Disease Report In a press release, Dr. Olsen said, “This represents the next generation of potential Duchenne muscular dystrophy therapies. By leveraging the revolutionary CRISPR/Cas9 method to permanently correct errors in the DNA sequence, it is our hope that we … Nonprofit Seeds Exonics to Fund Push For CRISPR Duchenne TreatmentXconomy CureDuchenne Ventures Invests in New Gene Editing Company Exonics Therapeutics to Advance CRISPR/Cas9 …Business Wire (press release) Exonics to use CRISPR in an effort to treat majority of DMD boysFierceBiotech GlobeNewswire (press release) –Genetic Engineering & Biotechnology News –Endpoints News all 10 news articles » |
Phys.Org |
Study shows stem cells fiercely abide by innate developmental timing
Phys.Org “The promising thing is that we can take species of stem cells, put them in tissue culture, and more confidently believe that events we’re seeing are probably happening in the wild as well,” Barry says. “That is potentially great news for studying … |
Phys.Org |
Super resolution imaging helps determine a stem cell’s future
Phys.Org Understanding a stem cell’s fate—the type of cell it will eventually become—and how far along it is in the process of development can help scientists better manipulate cells for stem cell therapy. The beauty of the method is its simplicity and … -exploring-what-stem–cells-can-do-now-and-in-the-futurethepaper24-7.com Mesenchymal Stem Cells Market Pegged for Robust Expansion by 2020Medgadget (blog) Scientists rejuvenate blood by “resetting” stem cellsPanARMENIAN.Net Oncology Nurse Advisor all 8 news articles » |